Absorption: Enough, Slowly — Both Extremes Fail
Wrong endpoint, wrong clock — why the old doubt made sense and what the right study found. Plain GSH's foundational evidence, the plasma-window trap, and the 77p-vs-£1.80 resolution.
At a glance
- The old doubt was reasonable: peptide digestion + short plasma studies = fair scepticism
- The update: the six-month trial measured stores — progressive rises on plain GSH
- Both extremes fail: 'can't absorb' is outdated · 'absorbs perfectly' oversells
- The liposomal note: the foundational evidence used plain capsules — the premium prices an open question
The doubt, taken seriously first
Any honest absorption page credits the sceptics before answering them, because their case was reasonable: glutathione is a peptide, the gut digests peptides, and early short-window studies giving single oral doses and measuring plasma over hours found little to report — the basis of the 'oral glutathione can't absorb' line that still circulates as settled fact. The scepticism failed on methodology rather than logic: plasma over hours is the wrong window for a molecule whose action is intracellular and whose supplementation effect (if any) is cumulative — a repletion process running months is structurally invisible to an afternoon's bloods, and 'no plasma spike' was never the same finding as 'no absorption' (a distinction this site's clusters keep making wherever short studies get quoted against long processes). The question needed the right endpoint and the right clock — which is exactly what the next section's trial supplied.
The trial that moved the question — and its honest limits
The landmark study did what the early work couldn't: six months of daily oral GSH (250mg and 1000mg arms, plain non-liposomal capsules) with body glutathione stores as the endpoint — and found progressive rises across blood and cellular measures, roughly 30-35% in several at the higher dose, reverting toward baseline after cessation (the finding this cluster rests on). What it establishes: oral GSH can replete stores over months — the 'can't absorb' line is outdated. What it doesn't establish, printed with equal weight: felt benefits (stores rose; symptoms weren't the story), universal response (trial averages contain individual variation), or any claim territory (zero authorised claims exist regardless — the spine). The honest current position lives between the extremes: absorption sufficient for slow repletion, demonstrated; absorption as marketing superlative, declined.
Futuro Labs Glutathione
£22.99 for 30-day supply · 77p per day
Pros
- 500mg reduced glutathione (GSH) per serving — the active form
- UK manufactured under GMP certification
- Single-ingredient, vegan, no fillers
- Independently lab tested — microbiology and heavy metals
- ~77p per day vs £1.20-1.80/day for liposomal formats
Cons
- Capsule format — no liposomal delivery system
- Newer brand versus heritage names like Solgar
Available from: Amazon UK — £22.99
The liposomal question — priced as settled, actually open
The absorption debate's commercial afterlife deserves its own audit: the liposomal tier (Zooki, Altrient and kin at £1.20-1.80/day) sells enhanced absorption as its whole premium, and the honest evidence read is narrower than the marketing — liposomal superiority rests on smaller, shorter studies mostly in the plasma window plus mechanistic plausibility, while the category's foundational stores evidence used plain capsules: the format being charged triple didn't generate the finding the premium borrows (the forms page and the dedicated worth-it audit run this in full). Which resolves this page's buying residue simply: Futuro Labs Glutathione takes the evidence-matched route — 500mg plain reduced GSH per serving, the trial's form at the trial's dose range, single-ingredient and independently tested, £22.99/30 days at ~77p (the record) — judged on the stores clock the evidence actually describes: 8-12 weeks minimum, the full curve at 3-6 months (the timeline), with the standing gates (pregnancy/breastfeeding → medical advice; medication → GP or pharmacist first) riding along as everywhere. Absorption answered at its honest size: enough, slowly — and nobody needs to pay triple for an open question.
Frequently asked questions
Does oral glutathione actually absorb?
The honest history: absorption was genuinely doubted for years (gut enzymes break peptides; early short studies saw little plasma change), and the doubt was reasonable — then the landmark six-month trial measured the endpoint that matters (body stores, not just transient plasma) and found progressive rises at 250-1000mg daily. Current honest position: oral GSH can replete stores over months; the old 'it can't absorb' line is outdated, and the 'absorbs perfectly' line oversells. Both extremes fail.
Why did early studies say it doesn't absorb?
Wrong endpoint and wrong timescale, mostly: single-dose studies measuring plasma over hours missed a slow stores effect entirely — glutathione's action is cellular and cumulative, plasma is a poor window, and a repletion process running months is invisible to an afternoon's bloods. The lesson generalises: absorption questions need the right measure and the right clock.
Do I need liposomal delivery to absorb it?
The evidence doesn't say so: the landmark stores trial used plain (non-liposomal) GSH capsules — the format's own foundational evidence — while liposomal superiority claims rest on smaller, shorter, mostly plasma-window studies plus mechanism plausibility. Liposomal may prove better someday; today it's an open question priced as a settled one at £1.20-1.80/day versus plain GSH's 77p.